| Abstrakt: |
[Objectives] To establish a new management model for rational use of perioperative antibacterial drugs in surgical departments. [Methods] Based on evidence-based medicine, the department's drug pathway was formulated, and the new mode of rational drug use control was established by using fine pharmaceutical technology intervention, and the intervention effect was evaluated by the intensity of antibacterial drug use, per capita drug costs and the proportion of drugs. [Results] After adopting drug pathway in departments, the intensity of antibacterial drug use, per capita drug costs and the proportion of drugs decreased significantly, and the effect of rational drug use control was remarkable. [Conclusions] The drug pathway provides a new management and control mode for the rational use of perioperative antibacterial drugs in surgical departments of hospitals. Thus, it is worthy of popularization and application. [ABSTRACT FROM AUTHOR] |
